Your browser doesn't support javascript.
loading
Establishment and Characterization of Four Novel Thyroid Cancer Cell Lines and PDX Models Expressing the RET/PTC1 Rearrangement, BRAFV600E, or RASQ61R as Drivers.
Schweppe, Rebecca E; Pozdeyev, Nikita; Pike, Laura A; Korch, Christopher; Zhou, Qiong; Sams, Sharon B; Sharma, Vibha; Pugazhenthi, Umarani; Raeburn, Christopher; Albuja-Cruz, Maria B; Reigan, Philip; LaBarbera, Daniel V; Landa, Iñigo; Knauf, Jeffrey A; Fagin, James A; Haugen, Bryan R.
Afiliación
  • Schweppe RE; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado. rebecca.schweppe@ucdenver.edu.
  • Pozdeyev N; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Pike LA; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Korch C; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Zhou Q; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Sams SB; Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Sharma V; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Pugazhenthi U; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Raeburn C; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Albuja-Cruz MB; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Reigan P; Department of Medicine, Division of Endocrinology, Diabetes and Metabolism, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • LaBarbera DV; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Landa I; Department of Surgery, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Knauf JA; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Fagin JA; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado.
  • Haugen BR; Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, New York.
Mol Cancer Res ; 17(5): 1036-1048, 2019 05.
Article en En | MEDLINE | ID: mdl-30733375

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Neoplasias de la Tiroides / Proteínas de Fusión Oncogénica / Proteínas Proto-Oncogénicas p21(ras) / Adenocarcinoma Folicular / Proteínas Proto-Oncogénicas B-raf / Carcinoma Anaplásico de Tiroides Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Tirosina Quinasas / Neoplasias de la Tiroides / Proteínas de Fusión Oncogénica / Proteínas Proto-Oncogénicas p21(ras) / Adenocarcinoma Folicular / Proteínas Proto-Oncogénicas B-raf / Carcinoma Anaplásico de Tiroides Tipo de estudio: Prognostic_studies Límite: Aged / Animals / Female / Humans / Middle aged Idioma: En Revista: Mol Cancer Res Asunto de la revista: BIOLOGIA MOLECULAR / NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Estados Unidos